Brief: Cstone Pharmaceuticals Says CEO Purchased Total Of 570,000 Shares In Open Market Since Nov
21/11/2022 12:12
Nov 21 (Reuters) - CStone Pharmaceuticals 2616.HK :
* CEO PURCHASED TOTAL OF 570,000 SHARES IN OPEN MARKET SINCE
NOVEMBER
* CEO'S SHAREHOLDING INTEREST IN CO WAS 3.88% OF TOTAL
ISSUED
SHARE CAPITAL OF CO AS AT NOV 21
Source text for Eikon: ID:
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026